Skip to main content
. 2021 Jun 21;10(6):1562. doi: 10.3390/cells10061562

Figure 11.

Figure 11

Eritoran decreased the MyD88-mediated p38/JNK phosphorylation in KC cells. Western blot analysis and quantification of myeloid differentiation factor 88 (MyD88), phosphorylated and total p38 (p/t-p38) and c-Jun N-terminal kinase (p/t-JNK) and transforming growth factor-β1 (TGF-β1) of primary KCs from the different treatment (n = 4/group). The isolated KCs were incubated with the siRNA control (Ctrl) (30 nM) or MyD88-siRNA (30 nM) for 48 h. After transfection, the cells were treated with or without LPS (10 ng/mL) or eritoran (10 μg/mL) for 6 h; # p < 0.05 vs. the group treated only with the siRNA control; * p < 0.05 vs. the group treated with the siRNA control and eritoran.